Internal Medicine 1104 - Internal Medicine Alert - Feb 28, 2007

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of California
Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky;
Director
Sleep Disorders Center
Samaritan Hospital
Lexington

Malcolm Robinson, MD, FACP, FACG
Emeritus Clinical Professor of Medicine
University of Oklahoma College of Medicine
Oklahoma City

Allan J. Wilke, MD
Residency Program Director
Associate Professor
Family Medicine
University of Alabama
Birmingham School of Medicine
Huntsville Regional Medical Campus
Huntsville

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Subjects:

  • Payers for Performance, Beware!
  • A Placebo-Controlled Trial of Pioglitazone in Subjects with NonAlcoholic Steatohepatitis
  • Quick Fix vs Delayed Gratification
  • Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy
  • Estradiol Gel 0.06% (Elestrin)
  • Clinical Briefs by Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens
  • Describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker’s bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD, associate editors Barbara A. Phillips, MD, MSPH, Malcolm Robinson, MD, FACP, FACG, Allan J. Wilke, MD, James Chan, PharmD, PhD, and William T. Elliott, MD, FACP report no financial relationship to this field of study. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2007 AHC Media. All rights reserved.